OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript May 12, 2026
OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.14, expectations were $0.01.
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx First Quarter Fiscal 26 Earnings Conference Call. With us today is chief executive officer, Stephen Silvestro He is joined by chief financial and strategy officer, Edward Stelmakh, Chief Legal and Administrative Officer Marion Odence-Ford,...
